Case / Specimen

Accession / Case #

Date of procedure

Specimen type

Tumor location (anatomic)

Clinical history

Primary Tumor / Pathologic Findings

Histologic type (CAP)

Grade (WHO / CAP)

Largest tumor dimension (cm)

Depth of invasion / pT (select)

AJCC 9 pT criteria (text included):

pTis = mucosa only;

pT1 = invades submucosa;

pT2 = invades muscularis propria;

pT3 = penetrates through muscularis propria into subserosa or pericolorectal tissues;

pT4a = tumor penetrates to surface of visceral peritoneum;

pT4b = tumor directly invades other organs/structures.

Use yp prefix for post-treatment.

Tumor deposits (N1c)

Perforation / serosal breach

Distance to closest radial / circumferential margin (mm)

Margin status

Lymphovascular invasion (LVI)

Perineural invasion (PNI)

Tumor budding

Additional tumor notes

Lymph Nodes

Total nodes examined

Positive nodes (macrometastasis)

Micrometastasis (0.2–2.0 mm)

Isolated tumor cells (<0.2 mm)

Extranodal extension (ENE)

Node details / mapping

AJCC 9 pN criteria (text included):

pN0 = no regional node metastasis;

pN0(i+) = ITCs only (<0.2 mm);

pN1mi = micrometastasis (0.2 - 2.0 mm);

pN1 = metastasis in 1 - 3 regional nodes OR tumor deposits N1c when nodes negative;

pN2 = metastasis in = > 4 regional nodes.

Record node counts, micrometastasis, ITCs, tumor deposits (N1c), and ENE.

Biomarkers & Molecular

MMR / IHC

MSI testing

KRAS

NRAS

BRAF V600E

Other molecular / comments

Note: MMR/MSI status affects prognosis and treatment (immunotherapy eligibility).

AJCC 9 Stage Group Guidance & Auto-staging

Stage 0: pTis, N0, M0.

Stage I: pT1 - 2, N0, M0.

Stage II: pT3 - 4, N0, M0 (IIA = pT3 N0; IIB = pT4a N0; IIC = pT4b N0).

Stage III: any T, N1 - 2, M0.

Stage IV: any T, any N, M1.

Enter pT (select or free text), pN (text or numeric), pM (text), and toggle yp flag. Stage group and rationale update automatically.

AJCC edition

Clinical T (cT)

Clinical N (cN)

Clinical M (cM)

Pathologic T (pT)

Pathologic N (pN)

Pathologic M (pM)

yp / post‑therapy flag

Stage group (auto)

Staging notes / rationale (auto)

Therapy / Response

Neoadjuvant therapy?

Pathologic response

Treatment / clinical notes

Pathologist summary & Actions

Diagnostic line(s) / Synoptic summary

Full pathologist comments

Signatory

Report date

Auto-save drafts

This auto-staging tool uses simplified AJCC 9 mapping to assist staging. Always verify final pT/pN/pM and stage group against the AJCC 9th Edition Cancer Staging Manual and institutional policy before signout.